News & Insights

16 September 2026 at Johnson & Johnson, Cambridge — an interactive exchange for pharma peers, hosted by ACCURIDS and ZS. Hybrid setup with limited seats on-site.

How do you prevent fragmented and inconsistent product data before it even exists?

For a global pharma with 1,000+ molecules across 165+ countries, ACCURIDS delivers an IDMP-native Product Data Backbone, audit-ready Golden Records for EMA PMS.

The Pistoia Alliance’s latest Community of Interest session showed the IDMP-Ontology in action - from public V1.4 availability and real-world adoption patterns to a live EMA PMS alignment demo.

Join us in Rotterdam from March 24-26 to discuss innovation, regulatory excellence, and the power of partnership.

Join us in Amsterdam this February as we discuss the pivotal shifts in pharmaceutical legislation, the transition to PMS, and the decommissioning of the Art 57 database.

Meet ACCURIDS at DIA RSIDM 2026 | Booth #212

Heiner Oberkampf outlines the path to a scalable Enterprise Knowledge Graph via GUPRIs, demonstrated by AstraZeneca’s real-world implementation of over 25 million governed identifiers.

How our collaborative EMA PMS Compliance Solution is setting a new standard for data quality and efficiency in life sciences.

Reflecting on four years of progress and the vital role of cross-industry collaboration with insights from the EMA, Boehringer Ingelheim, Johnson & Johnson, and more.

Insights from Europe's leading regulatory conference. Our key takeaways on data governance, EMA PMS' progress, and our joint talk with Boehringer Ingelheim.

Empowering pharmaceutical companies with trusted, standardized product data

How a Top 10 Pharma Company Built an IDMP-Aligned Knowledge Graph in Under 100 Days with ACCURIDS

Facing a 2026 EMA deadline, one global pharma leader achieved a 200% ROI and reduced manual work by 75% in under 12 months.

Why the management of reference data management cannot be centralized, and how easy-to-use global lookup services effectively increase findability, reuse, and interoperability.

Insights from the DIA 2024 workshop on tackling "standards fatigue" with a domain-focused IDMP strategy that delivers measurable value and reduces industry burnout.

Discussions at the summit confirmed the industry's digital transformation, with Regulatory Affairs evolving into a strategic partner driven by structured data, AI, and global standards.

At the Madrid Connectathon, we collaborated with UMC and NOMA to integrate PhPIDs and GSIDs into FHIR, demonstrating improved global medicine traceability via a Knowledge Graph.

The message from LIMICS Day was clear: facing challenges like supply shortages, the time to act is now to accelerate medicine digitalization with ISO IDMP.

Highlights from the ISO TC 215 / WG6 meeting, where discussions reinforced that industry-regulator collaboration is critical to streamlining global processes and improving data interoperability.

A recap of our intensive three-day workshop at the Uppsala Monitoring Centre, focused on advancing the WHODrug Knowledge Graph through collaborative, hands-on efforts.

The conference reinforced a shared vision: Semantic standards and governance are key to unlocking automation, interoperability, and building more efficient global healthcare systems.

Our whitepaper equips regulatory leaders with a strategic roadmap to transform EMA PMS and IDMP compliance challenges into streamlined, competitive opportunities.

Highlights from the DIA RSIDM conference, where industry leaders agreed that deep collaboration and strong data governance are essential for unlocking the value of global standards.

Following the Global Pharmaceutical Regulatory Affairs Summit, here are the key takeaways on advancing IDMP with semantic standards, collaborative PoCs, and industry benchmarks.

Avoid costly implementation delays and failures. These 6 steps create a sustainable, data-centric foundation that turns regulatory pressure into a strategic advantage for your enterprise.